Soihtu DTx is a digital therapeutics company founded in 2023 and headquartered in Espoo, Finland. Backed by a decade of scientific research, the company harnesses gaming technology to deliver innovative mental health treatments and digital therapeutics for depression.
Subscribe to see Soihtu DTx’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Soihtu DTx is a digital therapeutics company headquartered in Finland. Its most recent funding round, Pre-Seed, closed in September 2024. Xcout tracks 5 named people at Soihtu DTx, including Jukka Laakso (Chief Executive Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | Undisclosed | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Soihtu DTx's closest competitors — see the full list of competitors and alternatives →
Litesprite, Inc. is a digital health and gaming company headquartered in Bellevue, Washington, that develops therapeutic video games such as Sinasprite.
Prosoma is a digital health technology innovator founded in 2018 with its registered seat in Poland and operational presence in Amsterdam, the Netherlands. The company develops digital therapeutics designed to reinvent healthcare and redefine patient mental well-being.
Memory Lane Games Corp provides a digital health application featuring frustration-free games designed to stimulate memory, speech, and visual reasoning for individuals living with dementia and Alzheimer's. The platform also offers educational resources, tips, and support services to help family members and caregivers manage and cope with caregiving.
VRelax BV is a Dutch software supplier founded in 2018 and headquartered in Groningen, Netherlands, offering virtual reality relaxation and mental health solutions.
ReSet Therapeutics, operating through PursueCare, provides FDA-authorized prescription digital therapeutics designed to aid patients undergoing outpatient treatment for substance use and opioid use disorders. The smartphone applications deliver interactive cognitive behavioral therapy, track triggers and cravings, and connect patients with their healthcare providers to support long-term recovery.
GrayMatters Health provides interventional psychiatry solutions and digital biomarker technology designed to augment standard mental health care for conditions such as PTSD and depression. Its flagship product, Prism, utilizes fMRI-informed digital biomarkers and computer simulations to help patients learn self-neuromodulation techniques in clinical settings. The company serves psychiatry clinics and mental health providers by integrating these personalized treatments into standard operational workflows.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.